Bruce Jackson
Stock Analyst at Benchmark
(0.92)
# 3,874
Out of 4,984 analysts
122
Total ratings
27.03%
Success rate
-22.76%
Average return
Main Sectors:
Stocks Rated by Bruce Jackson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CV CapsoVision | Initiates: Speculative Buy | $5 | $4.48 | +11.61% | 1 | Jul 28, 2025 | |
| BFRI Biofrontera | Maintains: Buy | $7 → $2.75 | $0.87 | +215.80% | 8 | May 19, 2025 | |
| HUMA Humacyte | Maintains: Buy | $17 → $14 | $1.57 | +791.72% | 15 | May 14, 2025 | |
| HBIO Harvard Bioscience | Maintains: Speculative Buy | $4.5 → $3 | $0.48 | +518.68% | 6 | May 13, 2025 | |
| CLNN Clene | Maintains: Buy | $84 → $33 | $6.33 | +421.33% | 8 | May 8, 2025 | |
| GNLX Genelux | Maintains: Speculative Buy | $25 → $23 | $4.09 | +462.35% | 7 | May 8, 2025 | |
| BLTE Belite Bio | Reiterates: Buy | $80 | $66.90 | +19.58% | 9 | Mar 26, 2025 | |
| NEO NeoGenomics | Reiterates: Hold | n/a | $7.99 | - | 8 | Jan 16, 2025 | |
| EXAS Exact Sciences | Reiterates: Buy | $65 | $52.94 | +22.78% | 7 | Jan 13, 2025 | |
| VNRX VolitionRx | Reiterates: Hold | n/a | $0.64 | - | 3 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $30 | $3.99 | +651.88% | 8 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $1.25 | $0.58 | +115.55% | 2 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $3 | $1.83 | +63.93% | 3 | Oct 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $5 | $1.93 | +159.07% | 4 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $30 | $0.69 | +4,227.76% | 2 | Sep 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $60 | $3.89 | +1,443.21% | 5 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $17 | $0.40 | +4,189.68% | 4 | Aug 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $24 | $1.23 | +1,851.22% | 3 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $5 | $0.70 | +614.69% | 4 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.42 | - | 7 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $27.23 | - | 7 | Sep 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Speculative Buy | $800 | $3.47 | +22,954.76% | 1 | Aug 8, 2022 |
CapsoVision
Jul 28, 2025
Initiates: Speculative Buy
Price Target: $5
Current: $4.48
Upside: +11.61%
Biofrontera
May 19, 2025
Maintains: Buy
Price Target: $7 → $2.75
Current: $0.87
Upside: +215.80%
Humacyte
May 14, 2025
Maintains: Buy
Price Target: $17 → $14
Current: $1.57
Upside: +791.72%
Harvard Bioscience
May 13, 2025
Maintains: Speculative Buy
Price Target: $4.5 → $3
Current: $0.48
Upside: +518.68%
Clene
May 8, 2025
Maintains: Buy
Price Target: $84 → $33
Current: $6.33
Upside: +421.33%
Genelux
May 8, 2025
Maintains: Speculative Buy
Price Target: $25 → $23
Current: $4.09
Upside: +462.35%
Belite Bio
Mar 26, 2025
Reiterates: Buy
Price Target: $80
Current: $66.90
Upside: +19.58%
NeoGenomics
Jan 16, 2025
Reiterates: Hold
Price Target: n/a
Current: $7.99
Upside: -
Exact Sciences
Jan 13, 2025
Reiterates: Buy
Price Target: $65
Current: $52.94
Upside: +22.78%
VolitionRx
Nov 22, 2024
Reiterates: Hold
Price Target: n/a
Current: $0.64
Upside: -
Nov 22, 2024
Reiterates: Speculative Buy
Price Target: $30
Current: $3.99
Upside: +651.88%
Nov 20, 2024
Reiterates: Speculative Buy
Price Target: $1.25
Current: $0.58
Upside: +115.55%
Oct 11, 2024
Reiterates: Speculative Buy
Price Target: $3
Current: $1.83
Upside: +63.93%
Oct 10, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $1.93
Upside: +159.07%
Sep 4, 2024
Reiterates: Speculative Buy
Price Target: $30
Current: $0.69
Upside: +4,227.76%
Aug 27, 2024
Reiterates: Speculative Buy
Price Target: $60
Current: $3.89
Upside: +1,443.21%
Aug 26, 2024
Reiterates: Speculative Buy
Price Target: $17
Current: $0.40
Upside: +4,189.68%
Aug 14, 2024
Reiterates: Speculative Buy
Price Target: $24
Current: $1.23
Upside: +1,851.22%
Mar 21, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $0.70
Upside: +614.69%
Nov 14, 2023
Downgrades: Hold
Price Target: n/a
Current: $2.42
Upside: -
Sep 15, 2023
Downgrades: Hold
Price Target: n/a
Current: $27.23
Upside: -
Aug 8, 2022
Initiates: Speculative Buy
Price Target: $800
Current: $3.47
Upside: +22,954.76%